Merck KGaA (FRA:MRKC)

Market Cap	54.59B -11.6%
Revenue (ttm)	21.27B +1.5%
Net Income	2.96B +9.6%
EPS	6.80 +9.8%
Shares Out	n/a
PE Ratio	18.47
Forward PE	14.72
Dividend	0.30 (1.18%)
Ex-Dividend Date	Apr 29, 2025

Volume	4
Average Volume	0
Open	25.40
Previous Close	25.40
Day's Range	25.40 - 25.40
52-Week Range	20.40 - 30.60
Beta	n/a
RSI	52.67
Earnings Date	Mar 5, 2026

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 62,346
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MRKC

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.